GSK Adds Another ADC In Second Deal With Hansoh

Deal Snapshot: GSK is returning to its Chinese pharma partner Hansoh for a second ADC agreement, this time targeting B7-H3.

GSK licensed another ADC from Hansoh • Source: Shutterstock

More from Deals

More from Business